Taro Amagasaki

Efficacy and safety of omalizumab in an Asian population with moderate‐to‐severe persistent asthma

Ken Ohta, Terumasa Miyamoto, Taro Amagasaki et al. · Respirology · 2009 · 89 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Safety and efficacy of INC280 in combination with gefitinib (gef) in patients with <i>EGFR</i>-mutated (mut), MET-positive NSCLC: A single-arm phase lb/ll study.

Yi‐Long Wu, James Chih‐Hsin Yang, Dong‐Wan Kim et al. · Journal of Clinical Oncology · 2014 · 44 citations

Medicine, Oncology, Pharmacology +16

A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL

Arinobu Tojo, Kensuke Usuki, Akio Urabe et al. · International Journal of Hematology · 2009 · 40 citations

Medicine, Pharmacology, Pharmacotherapy +8

Efficacy and safety of ruxolitinib in Asian patients with myelofibrosis

Chul Won Jung, Lee‐Yung Shih, Zhijian Xiao et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2014 · 31 citations · Full text

Medicine, Hematology, Pharmacology +13

A randomized dose-escalation study to assess the safety, tolerability, and pharmacokinetics of ruxolitinib (INC424) in healthy Japanese volunteers

Yoichiro Ogama, Tomoko Mineyama, Asuka Yamamoto et al. · International Journal of Hematology · 2013 · 27 citations

Medicine, Pharmacokinetics, Pharmacology +9